Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Lisa M, Larkin"'
Autor:
Brittany L Rodriguez, Emmanuel E Vega-Soto, Christopher S Kennedy, Matthew H Nguyen, Paul S Cederna, Lisa M Larkin
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0239152 (2020)
Volumetric muscle loss (VML) is the loss of skeletal muscle that results in significant and persistent impairment of function. The unique characteristics of craniofacial muscle compared trunk and limb skeletal muscle, including differences in gene ex
Externí odkaz:
https://doaj.org/article/7d92095fb0ea47b682e9aaa2d80b6de0
Autor:
Brittany L. Rodriguez, Stoyna S. Novakova, Emmanuel E. Vega-Soto, Genevieve P. Nutter, Peter C.D. Macpherson, Lisa M. Larkin
Publikováno v:
Tissue Eng Part A
Tissue-engineered skeletal muscle is a promising novel therapy for the treatment of volumetric muscle loss (VML). Our laboratory has developed tissue-engineered skeletal muscle units (SMUs) and engineered neural conduits (ENCs), and modularly scaled
Publikováno v:
Neural Regeneration Research, Vol 12, Iss 9, Pp 1529-1537 (2017)
Damage to peripheral nerve tissue may cause loss of function in both the nerve and the targeted muscles it innervates. This study compared the repair capability of engineered nerve conduit (ENC), engineered fibroblast conduit (EFC), and autograft in
Externí odkaz:
https://doaj.org/article/d84de33d105a4272bedf95f648936873
Publikováno v:
Clinical oral investigations, vol 26, iss 7
Objective The aim of this study was to compare and characterize the structural and ultrastructural organization of the temporomandibular joint (TMJ) between two large animal models for use in the development of tissue engineering strategies. Material
Publikováno v:
Tissue Eng Part A
Skeletal muscle tissue engineering technologies have the potential to treat volumetric muscle loss (VML) by growing exogenous muscle tissue. However, there has been limited success in engineering human cell-sourced skeletal muscle with structure and
Publikováno v:
Tissue Eng Part A
Tissue engineering methodologies have the potential to treat volumetric muscle loss via the growth of exogenous skeletal muscle grafts from small autogenous muscle biopsies. A significant obstacle preventing the widespread use of engineered skeletal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deae9714b44f705122c187f1cc8c4dc9
https://europepmc.org/articles/PMC9131361/
https://europepmc.org/articles/PMC9131361/
Publikováno v:
Regenerative Engineering and Translational Medicine. 6:365-372
Volumetric muscle loss (VML) is traumatic, degenerative, or surgical loss of skeletal muscle that exceeds the regenerative capacity of the remaining muscle, thus resulting in impaired muscle function. In humans, the loss of 30% or more mass of any on
A Comparison of Ovine Facial and Limb Muscle as a Primary Cell Source for Engineered Skeletal Muscle
Autor:
Matthew H. Nguyen, Rachel E Armstrong, Phillip M. Polkowski, Brittany L. Rodriguez, Lisa M. Larkin, Emmanuel E Vega-Soto
Publikováno v:
Tissue Eng Part A
Volumetric muscle loss (VML) contributes to the number of soft tissue injuries that necessitate reconstructive surgery, but treatment options are often limited by tissue availability and donor site morbidity. To combat these issues, our laboratory ha
Autor:
Arlan Richardson, Susan V. Brooks, John A. Faulkner, Malcolm J. Jackson, Aphrodite Vasilaki, Lisa M. Larkin, Sathyaseelan S. Deepa, Holly Van Remmen, Anne McArdle
Publikováno v:
Free Radical Biology and Medicine. 132:19-23
Mice Jacking Cu/Zn-superoxide dismutase (Sod1(−/−) or sod1KO mice) show high levels of oxidative stress/damage and a 30% decrease in lifespan. The Sod1KO mice also show many phenotypes of accelerated aging with the loss of muscle mass and functio
Publikováno v:
Regen Eng Transl Med
Volumetric muscle loss (VML) is traumatic, degenerative, or surgical loss of skeletal muscle that exceeds the regenerative capacity of the remaining muscle, thus resulting in impaired muscle function. In humans, the loss of 30% or more mass of any on